Abstract
Fluconazole is standard treatment for oral candidiasis in HIV patients, but fluconazole-resistant candida strains are increasingly being encountered. Itraconazole, another azole antifungal agent, is effective for oral candidiasis but has less bioavailability than fluconazole. This study investigated a newly developed oral itraconazole solution …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
